Suppressor of Fused
Homo sapiens
State in the Current Structure
| Assembly | Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Associated Components | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|
| 1 | Protein homooligomer Homooligomer Protein × 4 PDB declaration: tetrameric(4) Consistent with protein copy count | Chain A; UniProt 27–262 Chain B; UniProt 27–262 Chain C; UniProt 27–262 Chain D; UniProt 27–262 | Fragment:N-terminal domain (Residues 27-262) | No other associated polymer | X-RAY DIFFRACTION X-ray crystallization conditions:VAPOR DIFFUSION, HANGING DROP;pH 6;279 K;1 M LiCl, 0.1 M NaCitrate pH 5.0- 6.0, 10% w/v PEG 6000, VAPOR DIFFUSION, HANGING DROP, temperature 279K | Resolution 2.65 Å R-free 0.256 |
Other States of the Same Protein in the Database
Each row is a biological assembly of the same UniProt protein in another PDB entry. The “Difference from current entry” column identifies evidence-level differences; no tag means the currently parsed fields agree.
| Other PDB | Difference from Current Entry 1M1L | Assembly / Oligomeric State | Construct | Mutations and Modifications | Ligands, Ions and Non-polymers | Method and Experimental Conditions | Structure Quality |
|---|---|---|---|---|---|---|---|
| 4BL8 Crystal structure of full-length human Suppressor of fused (SUFU) Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
32–483(452 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;PROTEIN (12 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS CRYSTALLISED AT 4OC BY HANGING DROP VAPOUR DIFFUSION WITH 0.2 M K/NA TARTRATE, 0.1 M BIS-TRIS PROPANE PH 8.5 AND 16% (V/V) PEG 3350 (AT A PROTEIN:MOTHER LIQUOR RATIO OF 2:1)
|
Resolution 3.04 Å R-free 0.246 |
| 4BL8 Crystal structure of full-length human Suppressor of fused (SUFU) Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
32–483(452 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;PROTEIN (12 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS CRYSTALLISED AT 4OC BY HANGING DROP VAPOUR DIFFUSION WITH 0.2 M K/NA TARTRATE, 0.1 M BIS-TRIS PROPANE PH 8.5 AND 16% (V/V) PEG 3350 (AT A PROTEIN:MOTHER LIQUOR RATIO OF 2:1)
|
Resolution 3.04 Å R-free 0.246 |
| 4BL9 Crystal structure of full-length human Suppressor of fused (SUFU) mutant lacking a regulatory subdomain (crystal form I) Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
32–278(247 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
Chain A
361–483(123 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;277 K;PROTEIN (6.5 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS CRYSTALLISED AT 4C BY HANGING DROP VAPOUR DIFFUSION WITH 0.08 M NA-CACODYLATE (PH 6.6), 20% (V/V) GLYCEROL, 160 MM CA(OAC)2 AND 9% (V/V) PEG 8000
|
Resolution 2.80 Å R-free 0.234 |
| 4BL9 Crystal structure of full-length human Suppressor of fused (SUFU) mutant lacking a regulatory subdomain (crystal form I) Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
32–278(247 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
Chain B
361–483(123 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;277 K;PROTEIN (6.5 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS CRYSTALLISED AT 4C BY HANGING DROP VAPOUR DIFFUSION WITH 0.08 M NA-CACODYLATE (PH 6.6), 20% (V/V) GLYCEROL, 160 MM CA(OAC)2 AND 9% (V/V) PEG 8000
|
Resolution 2.80 Å R-free 0.234 |
| 4BL9 Crystal structure of full-length human Suppressor of fused (SUFU) mutant lacking a regulatory subdomain (crystal form I) Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 3 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
32–278(247 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
Chain C
361–483(123 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;277 K;PROTEIN (6.5 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS CRYSTALLISED AT 4C BY HANGING DROP VAPOUR DIFFUSION WITH 0.08 M NA-CACODYLATE (PH 6.6), 20% (V/V) GLYCEROL, 160 MM CA(OAC)2 AND 9% (V/V) PEG 8000
|
Resolution 2.80 Å R-free 0.234 |
| 4BL9 Crystal structure of full-length human Suppressor of fused (SUFU) mutant lacking a regulatory subdomain (crystal form I) Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 4 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain D
32–278(247 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
Chain D
361–483(123 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 6.6;277 K;PROTEIN (6.5 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS CRYSTALLISED AT 4C BY HANGING DROP VAPOUR DIFFUSION WITH 0.08 M NA-CACODYLATE (PH 6.6), 20% (V/V) GLYCEROL, 160 MM CA(OAC)2 AND 9% (V/V) PEG 8000
|
Resolution 2.80 Å R-free 0.234 |
| 4BLA Crystal structure of full-length human Suppressor of fused (SUFU) mutant lacking a regulatory subdomain (crystal form II) Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
32–278(247 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
Chain A
361–483(123 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PROTEIN (11.6 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT) WAS CRYSTALLISED BY HANGING DROP VAPOUR DIFFUSION AT 4C WITH 0.1 M NA-HEPES PH 7.5, 17% (V/V) PEG 3350, 0.2 M NACL.
|
Resolution 3.50 Å R-free 0.293 |
| 4BLA Crystal structure of full-length human Suppressor of fused (SUFU) mutant lacking a regulatory subdomain (crystal form II) Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain B
32–278(247 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
Chain B
361–483(123 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PROTEIN (11.6 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT) WAS CRYSTALLISED BY HANGING DROP VAPOUR DIFFUSION AT 4C WITH 0.1 M NA-HEPES PH 7.5, 17% (V/V) PEG 3350, 0.2 M NACL.
|
Resolution 3.50 Å R-free 0.293 |
| 4BLA Crystal structure of full-length human Suppressor of fused (SUFU) mutant lacking a regulatory subdomain (crystal form II) Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 3 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain C
32–278(247 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
Chain C
361–483(123 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PROTEIN (11.6 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT) WAS CRYSTALLISED BY HANGING DROP VAPOUR DIFFUSION AT 4C WITH 0.1 M NA-HEPES PH 7.5, 17% (V/V) PEG 3350, 0.2 M NACL.
|
Resolution 3.50 Å R-free 0.293 |
| 4BLA Crystal structure of full-length human Suppressor of fused (SUFU) mutant lacking a regulatory subdomain (crystal form II) Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 4 Insufficient information Monomer;Protein × 1 PDB declaration: monomeric |
Chain D
32–278(247 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
Chain D
361–483(123 aa)
Fragment:MBPP RESIDUES 29-387,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PROTEIN (11.6 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT) WAS CRYSTALLISED BY HANGING DROP VAPOUR DIFFUSION AT 4C WITH 0.1 M NA-HEPES PH 7.5, 17% (V/V) PEG 3350, 0.2 M NACL.
|
Resolution 3.50 Å R-free 0.293 |
| 4BLB Crystal structure of a human Suppressor of fused (SUFU)-GLI1p complex Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
32–278(247 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain C
361–453(93 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain C
457–483(27 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES Mutation:YES | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PROTEIN (10 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS MIXED IN A 1:1 MOLAR RATIO WITH ZN(OAC)2 AND A 1:4 MOLAR RATIO WITH GLI1 PEPTIDE. THE COMPLEX WAS CRYSTALLISED BY HANGING DROP VAPOUR DIFFUSION AT 4C WITH 1:1 OR 2:1 DROPS OF PROTEIN:WELL SOLUTION (14-18% (V/V) PEG 3350, AND 0.2 M NA FORMATE)
|
Resolution 2.80 Å R-free 0.234 |
| 4BLB Crystal structure of a human Suppressor of fused (SUFU)-GLI1p complex Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
32–278(247 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain A
361–453(93 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain A
457–483(27 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES Mutation:YES | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PROTEIN (10 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS MIXED IN A 1:1 MOLAR RATIO WITH ZN(OAC)2 AND A 1:4 MOLAR RATIO WITH GLI1 PEPTIDE. THE COMPLEX WAS CRYSTALLISED BY HANGING DROP VAPOUR DIFFUSION AT 4C WITH 1:1 OR 2:1 DROPS OF PROTEIN:WELL SOLUTION (14-18% (V/V) PEG 3350, AND 0.2 M NA FORMATE)
|
Resolution 2.80 Å R-free 0.234 |
| 4BLB Crystal structure of a human Suppressor of fused (SUFU)-GLI1p complex Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
32–278(247 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain D
361–453(93 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain D
457–483(27 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES Mutation:YES | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PROTEIN (10 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS MIXED IN A 1:1 MOLAR RATIO WITH ZN(OAC)2 AND A 1:4 MOLAR RATIO WITH GLI1 PEPTIDE. THE COMPLEX WAS CRYSTALLISED BY HANGING DROP VAPOUR DIFFUSION AT 4C WITH 1:1 OR 2:1 DROPS OF PROTEIN:WELL SOLUTION (14-18% (V/V) PEG 3350, AND 0.2 M NA FORMATE)
|
Resolution 2.80 Å R-free 0.234 |
| 4BLB Crystal structure of a human Suppressor of fused (SUFU)-GLI1p complex Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
32–278(247 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain B
361–453(93 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain B
457–483(27 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES Mutation:YES | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PROTEIN (10 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS MIXED IN A 1:1 MOLAR RATIO WITH ZN(OAC)2 AND A 1:4 MOLAR RATIO WITH GLI1 PEPTIDE. THE COMPLEX WAS CRYSTALLISED BY HANGING DROP VAPOUR DIFFUSION AT 4C WITH 1:1 OR 2:1 DROPS OF PROTEIN:WELL SOLUTION (14-18% (V/V) PEG 3350, AND 0.2 M NA FORMATE)
|
Resolution 2.80 Å R-free 0.234 |
| 4BLD Crystal structure of a human Suppressor of fused (SUFU)-GLI3p complex Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
32–278(247 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain A
361–453(93 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain A
457–483(27 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES Mutation:YES | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PROTEIN (10 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS MIXED IN A 1:1 MOLAR RATIO WITH ZN(OAC)2 AND A 1:4 MOLAR RATIO WITH GLI3 PEPTIDE. THE COMPLEX WAS CRYSTALLISED BY HANGING DROP VAPOUR DIFFUSION AT 4C WITH 1:1 OR 2:1 DROPS OF PROTEIN:WELL SOLUTION (14-18% (V/V) PEG 3350 AND 0.2 M NA FORMATE)
|
Resolution 2.80 Å R-free 0.234 |
| 4BLD Crystal structure of a human Suppressor of fused (SUFU)-GLI3p complex Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain C
32–278(247 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain C
361–453(93 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain C
457–483(27 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES Mutation:YES | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PROTEIN (10 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS MIXED IN A 1:1 MOLAR RATIO WITH ZN(OAC)2 AND A 1:4 MOLAR RATIO WITH GLI3 PEPTIDE. THE COMPLEX WAS CRYSTALLISED BY HANGING DROP VAPOUR DIFFUSION AT 4C WITH 1:1 OR 2:1 DROPS OF PROTEIN:WELL SOLUTION (14-18% (V/V) PEG 3350 AND 0.2 M NA FORMATE)
|
Resolution 2.80 Å R-free 0.234 |
| 4BLD Crystal structure of a human Suppressor of fused (SUFU)-GLI3p complex Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 3 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain B
32–278(247 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain B
361–453(93 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain B
457–483(27 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES Mutation:YES | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PROTEIN (10 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS MIXED IN A 1:1 MOLAR RATIO WITH ZN(OAC)2 AND A 1:4 MOLAR RATIO WITH GLI3 PEPTIDE. THE COMPLEX WAS CRYSTALLISED BY HANGING DROP VAPOUR DIFFUSION AT 4C WITH 1:1 OR 2:1 DROPS OF PROTEIN:WELL SOLUTION (14-18% (V/V) PEG 3350 AND 0.2 M NA FORMATE)
|
Resolution 2.80 Å R-free 0.234 |
| 4BLD Crystal structure of a human Suppressor of fused (SUFU)-GLI3p complex Deposited 2013-05-02 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 4 Insufficient information Heteromer;Protein × 2 PDB declaration: dimeric |
Chain D
32–278(247 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain D
361–453(93 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
Chain D
457–483(27 aa)
Fragment:MBPP RESIDUES 29-392,SUFUH RESIDUES 32-278,361-483
|
Mutation:YES Mutation:YES Mutation:YES | ZN ZINC ION × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;pH 7.5;277 K;PROTEIN (10 MG/ML IN 10 MM TRIS-HCL PH 7.5, 50 MM NACL, 1 MM DTT, 1 MM MALTOSE) WAS MIXED IN A 1:1 MOLAR RATIO WITH ZN(OAC)2 AND A 1:4 MOLAR RATIO WITH GLI3 PEPTIDE. THE COMPLEX WAS CRYSTALLISED BY HANGING DROP VAPOUR DIFFUSION AT 4C WITH 1:1 OR 2:1 DROPS OF PROTEIN:WELL SOLUTION (14-18% (V/V) PEG 3350 AND 0.2 M NA FORMATE)
|
Resolution 2.80 Å R-free 0.234 |
| 4KM8 Crystal structure of Sufud60 Deposited 2013-05-08 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–285(285 aa)
Fragment:UNP RESIDUES 1-285, 346-484
Chain A
346–484(139 aa)
Fragment:UNP RESIDUES 1-285, 346-484
|
Mutation:Deletion 286-345 Non-standard monomer:Yes (specific site not provided by mmCIF) Mutation:Deletion 286-345 Non-standard monomer:Yes (specific site not provided by mmCIF) | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;287 K;8% PEG 3350, 0.15M Ammonium Tartrate, vapor diffusion, hanging drop, temperature 287K
|
Resolution 2.26 Å R-free 0.259 |
| 4KM9 Crystal structure of human Suppressor of Fused Deposited 2013-05-08 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein monomer Monomer;Protein × 1 PDB declaration: monomeric |
Chain A
1–484(484 aa)
|
Not recorded | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;281 K;20% PEG 3350, 0.2M Potassium chloride, vapor diffusion, hanging drop, temperature 281K
|
Resolution 3.19 Å R-free 0.305 |
| 4KMD Crystal structure of Sufud60-Gli1p Deposited 2013-05-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 1 Protein heterocomplex Heteromer;Protein × 2 PDB declaration: dimeric |
Chain A
1–285(285 aa)
Fragment:UNP RESIDUES 1-285, 346-484
Chain A
346–484(139 aa)
Fragment:UNP RESIDUES 1-285, 346-484
|
Not recorded | GOL GLYCEROL × 6 DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE × 1 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;20% PEG 3350, 0.2M Magnesium Chloride, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.70 Å R-free 0.222 |
| 4KMD Crystal structure of Sufud60-Gli1p Deposited 2013-05-08 | Different construct Different mutation/modification Different oligomeric state Different ligand/ion Different experimental conditions Different structure-quality metrics | Assembly 2 Protein heterocomplex Heteromer;Protein × 4 PDB declaration: tetrameric |
Chain A
1–285(285 aa)
Fragment:UNP RESIDUES 1-285, 346-484
Chain A
346–484(139 aa)
Fragment:UNP RESIDUES 1-285, 346-484
|
Not recorded | GOL GLYCEROL × 12 DTT 2,3-DIHYDROXY-1,4-DITHIOBUTANE × 2 |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;277 K;20% PEG 3350, 0.2M Magnesium Chloride, vapor diffusion, hanging drop, temperature 277K
|
Resolution 1.70 Å R-free 0.222 |
| 4KMH Crystal structure of Suppressor of Fused d20 Deposited 2013-05-08 | Different construct Different mutation/modification Different oligomeric state Different experimental conditions Different structure-quality metrics | Assembly 1 Protein homooligomer Homooligomer;Protein × 2 PDB declaration: dimeric |
Chain A
1–305(305 aa)
Fragment:UNP RESIDUES 1-305, 326-484
Chain A
326–484(159 aa)
Fragment:UNP RESIDUES 1-305, 326-484
Chain B
1–305(305 aa)
Fragment:UNP RESIDUES 1-305, 326-484
Chain B
326–484(159 aa)
Fragment:UNP RESIDUES 1-305, 326-484
|
Mutation:DELETION RESIDUES 306-325 Mutation:DELETION RESIDUES 306-325 Mutation:DELETION RESIDUES 306-325 Mutation:DELETION RESIDUES 306-325 | No recorded non-water small molecule |
X-RAY DIFFRACTION
X-ray crystallization conditions
VAPOR DIFFUSION, HANGING DROP;287 K;16% PEG 3350, 0.1M Ammonium Tartrate, vapor diffusion, hanging drop, temperature 287K
|
Resolution 3.04 Å R-free 0.277 |
9 other PDB entries and 23 assemblies. Open the comparison page and filter oligomeric states
View Construct and Data Evidence
| UniProt name | SUFU_HUMAN |
| Isoform | — |
| PDB entities | 1 |
| Chains and sequence ranges | Author chain A; PDBConstruct 1–236; UniProt 27–262 Author chain B; PDBConstruct 1–236; UniProt 27–262 Author chain C; PDBConstruct 1–236; UniProt 27–262 Author chain D; PDBConstruct 1–236; UniProt 27–262 |